Detalhe da pesquisa
1.
In Vitro Susceptibility to Closthioamide among Clinical and Reference Strains of Neisseria gonorrhoeae.
Antimicrob Agents Chemother
; 61(10)2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28784667
2.
Improving the diagnosis of tuberculosis: old and new laboratory tools.
Expert Rev Mol Diagn
; : 1-10, 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38832527
3.
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
Lancet Infect Dis
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768617
4.
Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid.
PLOS Glob Public Health
; 3(10): e0002283, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851685
5.
Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Molecular Typing of Acinetobacter baumannii in Comparison with Orthogonal Methods.
Microbiol Spectr
; 11(3): e0499522, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154773
6.
Whole genome sequencing and prediction of antimicrobial susceptibilities in non-tuberculous mycobacteria.
Front Microbiol
; 13: 1044515, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523832
7.
Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model.
Antibiotics (Basel)
; 10(12)2021 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34943727